Source: International Congress 2016 – The nature of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Elisabetta Gamen (Bad Nauheim, Germany), Elisabetta Gamen, Prakash Chelladurai, Friedrich Grimminger, Rajkumar Savai, Werner Seeger, Soni Savai Pullamsetti. LSC Abstract – Histone deacetylase 7 mediated metabolic remodeling: A new crosslink between pulmonary hypertension and cancer. Eur Respir J 2016; 48: Suppl. 60, 5105

Member's Comments

No comment yet.

Related content which might interest you: Implication of the histone methyltransferase EZH2 in pulmonary arterial hypertension Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 H3K27 histone lysine methylation as potential therapeutic target in pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Prevention of fetal programming of pulmonary vascular dysfunction by a histone deacetylase inhibitor Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 Role and regulation of Jumonji C domain-containing histone demethylases 1A and 2B in pulmonary hypertension Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 microRNA-223 suppresses histone deacetylase 2 in chronic obstructive pulmonary disease Source: International Congress 2015 – Latest news on miRNAs in pulmonary research Year: 2015 LSC Abstract – Epigenome-wide mapping of histone modification landscape in human pulmonary arterial hypertension Source: International Congress 2016 – New genomic targets in pulmonary disease Year: 2016 Decreased histone deacetylase activity in COPD Source: Annual Congress 2008 - Epigenetic modifications in lung disease Year: 2008 Aberrant expression and activity of histone deacetylases in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Histone deacetylase activity is reduced in COPD. Modulation by theophylline Source: Eur Respir J 2003; 22: Suppl. 45, 4s Year: 2003 Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice Source: Eur Respir J 2014; 43: 1448-1458 Year: 2014 Steroids and histone deacetylase in ventilation-induced gene transcription Source: Eur Respir J 2007; 30: 865-877 Year: 2007 Re-education of tumor-associated macrophages by modulating histone deacetylases in lung cancer Source: ERS Lung Science Conference 2017 Year: 2017 Involvement of coactivator associated arginine methyltransferase 1 (CARM1) in development of elastase-induced progressive emphysema Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 Histone deacetylase inhibitor panobinostat reduces hypoxia-related cisplatin resistance in NSCLC cells by HDAC-mediated Hifalpha destabilization Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Histone deacetylase activity and gene expression in COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 316s Year: 2001 Epigenome-wide mapping of histone modification landscape in human pulmonary arterial hypertension Source: ERS Lung Science Conference 2016 Year: 2016 The role of histone deacetylase 9 in the imbalance of Th17/Treg in bronchial asthma Source: Annual Congress 2012 - Mechanisms of asthma Year: 2012 Histone acetylation and deacetylation: importance in inflammatory lung diseases Source: Eur Respir J 2005; 25: 552-563 Year: 2005 Histone deacetylase inhibition significantly augments human mesothelioma cellular response to chemotherapeutic agents Source: Eur Respir J 2001; 18: Suppl. 33, 396s Year: 2001 Histone deacetylases (HDACs) and lung disease Source: Annual Congress 2011 - Why is epigenetics important for lung disease? Year: 2011